Design and rationale of the Research with EVuzamitide to Evaluate for cardiac AmyLoidosis (REVEAL) positron emission tomography study: A study of (124)I-evuzamitide to diagnose cardiac amyloidosis.

Dorbala S, Maurer MS, Cuddy SAM, Auer BD, Kijewski MF, Clerc OF, Khouri MG, Mitchell JD, Sperry BW, Hanna M, AbouEzzeddine OF, Malhotra S, Wall JS, Guthrie S, Di Carli MF, Ruberg FL, Dilsizian V, Dispenzieri A, Udelson JE, Narra RK, Masri AM

Open source

DOI: 10.1016/j.nuclcard.2026.102773
Published: 2026 Jul
Container: Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.nuclcard.2026.102773,
  title = {Design and rationale of the Research with EVuzamitide to Evaluate for cardiac AmyLoidosis (REVEAL) positron emission tomography study: A study of (124)I-evuzamitide to diagnose cardiac amyloidosis.},
  author = {Dorbala S and Maurer MS and Cuddy SAM and Auer BD and Kijewski MF and Clerc OF and Khouri MG and Mitchell JD and Sperry BW and Hanna M and AbouEzzeddine OF and Malhotra S and Wall JS and Guthrie S and Di Carli MF and Ruberg FL and Dilsizian V and Dispenzieri A and Udelson JE and Narra RK and Masri AM},
  year = {2026},
  journal = {Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology},
  doi = {10.1016/j.nuclcard.2026.102773},
  url = {https://doi.org/10.1016/j.nuclcard.2026.102773}
}

RIS

TY  - JOUR
TI  - Design and rationale of the Research with EVuzamitide to Evaluate for cardiac AmyLoidosis (REVEAL) positron emission tomography study: A study of (124)I-evuzamitide to diagnose cardiac amyloidosis.
AU  - Dorbala S
AU  - Maurer MS
AU  - Cuddy SAM
AU  - Auer BD
AU  - Kijewski MF
AU  - Clerc OF
AU  - Khouri MG
AU  - Mitchell JD
AU  - Sperry BW
AU  - Hanna M
AU  - AbouEzzeddine OF
AU  - Malhotra S
AU  - Wall JS
AU  - Guthrie S
AU  - Di Carli MF
AU  - Ruberg FL
AU  - Dilsizian V
AU  - Dispenzieri A
AU  - Udelson JE
AU  - Narra RK
AU  - Masri AM
PY  - 2026
JO  - Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
DO  - 10.1016/j.nuclcard.2026.102773
UR  - https://doi.org/10.1016/j.nuclcard.2026.102773
ER  -

APA

S, D., MS, M., SAM, C., BD, A., MF, K., OF, C., MG, K., JD, M., BW, S., M, H., OF, A., S, M., JS, W., S, G., MF, D. C., FL, R., V, D., A, D., JE, U., RK, N., & AM, M. (2026). Design and rationale of the Research with EVuzamitide to Evaluate for cardiac AmyLoidosis (REVEAL) positron emission tomography study: A study of (124)I-evuzamitide to diagnose cardiac amyloidosis.. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology. https://doi.org/10.1016/j.nuclcard.2026.102773

Source records

pubmed · retrieved 2026-09-25T18:53:26.895Z